Here's why Roche might buy Watertown's Tetraphase — and why Cubist probably won't

On Monday, Bloomberg cited unnamed sources in reporting that antibiotics developer Tetraphase is considering a sale to one of two Swiss drug giants...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.